Over 2,400 medical device manufacturers from around the world have signed up to use the Global Medical Device Nomenclature (GMDN), the de facto global standard for identifying the world’s millions of medical devices, since April 2019.
The GMDN is now used by over 5,200 registered member organisations around the world, which is an increase of 86%, in just 5 months.
The surge in use follows its introduction of a new free membership on 1 April 2019, which has seen a huge uptake from manufacturers. This allows them access to the core data, while the existing membership charges remain for manufacturers needing the time-saving and value-added services provided by the GMDN Agency.
Mark Wasmuth, the CEO of the GMDN Agency, said: “Healthcare product regulators have welcomed the introduction of the new free service, which helps to remove local objections to compliance costs, something that the World Health Organisation has recently campaigned to reduce."
John Wilkinson, the Chair of the GMDN Agency’s Board of Trustees, said: “After consulting with the industry, the GMDN Agency Board made a challenging decision to introduce the new membership scheme earlier this year. We are very pleased that thousands more manufacturers are now realising the benefit of using the GMDN, which has firmly established itself as the global naming convention for medical devices."
